Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.
Dávalos A, Cobo E, Molina CA, Chamorro A, de Miquel MA, Román LS, Serena J, López-Cancio E, Ribó M, Millán M, Urra X, Cardona P, Tomasello A, Castaño C, Blasco J, Aja L, Rubiera M, Gomis M, Renú A, Lara B, Martí-Fàbregas J, Jankowitz B, Cerdà N, Jovin TG; REVASCAT Trial Investigators. Dávalos A, et al. Lancet Neurol. 2017 May;16(5):369-376. doi: 10.1016/S1474-4422(17)30047-9. Epub 2017 Mar 16. Lancet Neurol. 2017. PMID: 28318984 Clinical Trial.
Favorable outcome of ischemic stroke in patients pretreated with statins.
Martí-Fàbregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvís R, Cocho D, Roquer J, Rodríguez A, García MD, Molina-Porcel L, Díaz-Manera J, Martí-Vilalta JL. Martí-Fàbregas J, et al. Stroke. 2004 May;35(5):1117-21. doi: 10.1161/01.STR.0000125863.93921.3f. Epub 2004 Apr 8. Stroke. 2004. PMID: 15073403
Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA.
Martí-Fàbregas J, Borrell M, Cocho D, Belvís R, Castellanos M, Montaner J, Pagonabarraga J, Aleu A, Molina-Porcel L, Díaz-Manera J, Bravo Y, Alvarez-Sabín J, Dávalos A, Fontcuberta J, Martí-Vilalta JL. Martí-Fàbregas J, et al. Neurology. 2005 Aug 9;65(3):366-70. doi: 10.1212/01.wnl.0000171704.50395.ba. Neurology. 2005. PMID: 16087899 Clinical Trial.
Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
Martí-Fàbregas J, Bravo Y, Cocho D, Martí-Vilalta JL, Díaz-Manera J, San Román L, Puig M, Blanco M, Castellanos M, Millán M, Roquer J, Obach V, Maestre J. Martí-Fàbregas J, et al. Cerebrovasc Dis. 2007;23(2-3):85-90. doi: 10.1159/000097043. Epub 2006 Nov 15. Cerebrovasc Dis. 2007. PMID: 17114877
KCNK17 genetic variants in ischemic stroke.
Domingues-Montanari S, Fernández-Cadenas I, Del Río-Espinola A, Mendioroz M, Fernandez-Morales J, Corbeto N, Delgado P, Ribó M, Rubiera M, Obach V, Martí-Fàbregas J, Freijo M, Serena J, Montaner J. Domingues-Montanari S, et al. Atherosclerosis. 2010 Jan;208(1):203-9. doi: 10.1016/j.atherosclerosis.2009.07.023. Epub 2009 Jul 31. Atherosclerosis. 2010. PMID: 19647252
Outcomes of intravenous thrombolysis after dissemination of the stroke code and designation of new referral hospitals in Catalonia: the Catalan Stroke Code and Thrombolysis (Cat-SCT) Monitored Study.
Abilleira S, Dávalos A, Chamorro A, Alvarez-Sabín J, Ribera A, Gallofré M; Catalan Stroke Code and Thrombolysis Study Group. Abilleira S, et al. Stroke. 2011 Jul;42(7):2001-6. doi: 10.1161/STROKEAHA.110.605030. Epub 2011 May 12. Stroke. 2011. PMID: 21566237
Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis.
Martinez-Ramirez S, Delgado-Mederos R, Marín R, Suárez-Calvet M, Sáinz MP, Alejaldre A, Vidal-Jordana Á, Martí-Vilalta JL, Martí-Fàbregas J. Martinez-Ramirez S, et al. J Neurol. 2012 Jan;259(1):111-8. doi: 10.1007/s00415-011-6137-3. Epub 2011 Jun 18. J Neurol. 2012. PMID: 21688044
Guidelines for the treatment of acute ischaemic stroke.
Alonso de Leciñana M, Egido JA, Casado I, Ribó M, Dávalos A, Masjuan J, Caniego JL, Martínez Vila E, Díez Tejedor E; ad hoc committee of the SEN Study Group for Cerebrovascular Diseases; Fuentes B, Álvarez-Sabin J, Arenillas J, Calleja S, Castellanos M, Castillo J, Díaz-Otero F, López-Fernández JC, Freijo M, Gállego J, García-Pastor A, Gil-Núñez A, Gilo F, Irimia P, Lago A, Maestre J, Martí-Fábregas J, Martínez-Sánchez P, Molina C, Morales A, Nombela F, Purroy F, Rodríguez-Yañez M, Roquer J, Rubio F, Segura T, Serena J, Simal P, Tejada J, Vivancos J; Spanish Neurological Society. Alonso de Leciñana M, et al. Neurologia. 2014 Mar;29(2):102-22. doi: 10.1016/j.nrl.2011.09.012. Epub 2011 Dec 6. Neurologia. 2014. PMID: 22152803 Free article. Review. English, Spanish.
Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients.
Fernández-Cadenas I, Del Río-Espínola A, Carrera C, Domingues-Montanari S, Mendióroz M, Delgado P, Rosell A, Ribó M, Giralt D, Quintana M, Castellanos M, Obach V, Martínez S, Freijo MM, Jiménez-Conde J, Roquer J, Martí-Fábregas J, Molina CA, Alvarez-Sabín J, Montaner J. Fernández-Cadenas I, et al. Stroke. 2012 May;43(5):1398-400. doi: 10.1161/STROKEAHA.111.639823. Epub 2012 Apr 10. Stroke. 2012. PMID: 22496335
284 results